Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Sensus Healthcare Inc is a medical devices business based in the US. Sensus Healthcare shares (SRTS) are listed on the NASDAQ and all prices are listed in US Dollars. Sensus Healthcare employs 37 staff and has a trailing 12-month revenue of around $41 million.
Our top pick for
Beginners
Our top pick for
Free trades
Our top pick for
Active traders
| Latest market close | $11.50 |
|---|---|
| 52-week range | $3.51 - $15.25 |
| 50-day moving average | $12.48 |
| 200-day moving average | $9.56 |
| Wall St. target price | $16.50 |
| PE ratio | 8.4418 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $1.46 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $11.5 from 2022-09-27
| 1 week (2022-09-21) | -15.63% |
|---|---|
| 1 month (2022-08-26) | -12.68% |
| 3 months (2022-06-28) | 43.57% |
| 6 months (2022-03-25) | 0.44% |
| 1 year (2021-09-28) | 221.23% |
|---|---|
| 2 years (2020-09-28) | 354.55% |
| 3 years (2019-09-27) | 91.35% |
| 5 years (2017-09-28) | 128.17% |
Valuing Sensus Healthcare stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Sensus Healthcare's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Sensus Healthcare's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 8x. In other words, Sensus Healthcare shares trade at around 8x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Sensus Healthcare's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $14.5 million.
The EBITDA is a measure of a Sensus Healthcare's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $41 million |
|---|---|
| Operating margin TTM | 34.2% |
| Gross profit TTM | $17 million |
| Return on assets TTM | 21.18% |
| Return on equity TTM | 76.92% |
| Profit margin | 61.27% |
| Book value | $2.72 |
| Market capitalisation | $204.1 million |
TTM: trailing 12 months
We're not expecting Sensus Healthcare to pay a dividend over the next 12 months.
Over the last 12 months, Sensus Healthcare's shares have ranged in value from as little as $3.505 up to $15.25. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sensus Healthcare's is 0.7667. This would suggest that Sensus Healthcare's shares are less volatile than average (for this exchange).
Sensus Healthcare, Inc. , a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc.
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
A simple guide to buying stocks in your favorite European soccer team.
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.